DRUGS related term(s) Crime; Pharmaceuticals

Addresses

State of the Union: President Trump, S645–S649 [24FE], H2287–H2295 [24FE]

Amendments

Accelerating Access to Critical Therapies for ALS Act: reauthorize (S. 4472), S4426 [4AU]

Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S165, S172 [13JA], S222 [14JA]

Dept. of Homeland Security: require updates to northern border threat analysis and northern border strategy (S. 850), S4480, S4481 [5AU]

Patents: address infringement of patents that claim biological products (S. 1041), S4198 [21JY]

Articles and editorials

Botched Care and Tired Staff—Planned Parenthood in Crisis, S3188 [24JN]

Bills and resolutions

Abortion: reaffirm safety of medication abortion and preempt State restrictions on dispensing medication abortion (see H.R. 8734), H3346 [11MY]

Accelerating Access to Critical Therapies for ALS Act: reauthorize (see S. 4472), S2171 [30AP] (see H.R. 8205), H2824 [6AP]

Agriculture: preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants (see H.R. 9830), H5174 [22JY]

Armed Forces: commend U.S. military action in Venezuela (see S. Res. 576), S115 [8JA]

——— furnish stellate ganglion block to members with post-traumatic stress disorder (see H.R. 8764), H3392 [12MY]

——— remove from unauthorized hostilities against Venezuela (see H. Con. Res. 68), H134 [7JA]

Bureau of Prisons: provide for civil commitment of persons who are danger to public safety (see H.R. 8452), H3067 [22AP]

——— provide medication assisted treatment for opioid addiction to pregnant women in custody (see H.R. 9756), H4623 [16JY]

CDC: advance population research for chronic pain (see S. 5041), S4187 [21JY]

Centers for Medicare & Medicaid Services: report on use of coverage and reimbursement authorities to protect markets for active pharmaceutical ingredients and key starting materials (see S. 5297), S4514 [6AU]

——— require Center for Medicare and Medicaid Innovation to test model implementing most-favored-nation drug pricing (see H.R. 7837), H2470 [5MR]

——— work with State Medicaid programs to issue guidance on impact of funding cuts and new requirements under One Big Beautiful Bill Act on State agencies and enrollees (see H. Res. 1403), H4364 [30JN]

Children and youth: prohibit gender transition procedures on minors and impose civil penalties on persons who perform such procedures on minors (see S. 4426), S2128 [29AP] (see H.R. 8573), H3294 [29AP]

Colleges and universities: provide for marijuana agricultural research program at 1890 Land-Grant Educational Institutions (see H.R. 9344), H4124 [18JN]

——— require that opioid overdose rescue kits be located at public institutions of higher education (see H.R. 8499), H3122 [27AP]

——— streamline process for institutions to research marijuana (see H.R. 8394), H2995 [20AP]

Controlled Substances Act: amend evaluation of substances reviewed for scheduling to more closely align with modern medical knowledge, terminology, and practices (see H.R. 9186), H3990 [8JN]

——— extend limitations period for certain offenses resulting in death or serious bodily injury (see S. 4209), S1614 [25MR]

Courts: establish Federal tort for harm to women caused by chemical abortion drugs (see S. 4066), S1009 [11MR] (see H.R. 7902), H2481 [12MR]

——— give Federal courts additional discretion to determine whether pretrial detention is appropriate for defendants charged with nonviolent drug offenses in Federal criminal cases (see S. 3960), S731 [2MR]

——— increase mandatory minimum sentencing penalties for drug traffickers and dealers convicted for distribution of fentanyl (see H.R. 9937), H5196 [23JY]

Crime: prevent importation of illicit pill press machines with intent to counterfeit substances (see S. 4446), S2170 [30AP] (see H.R. 7184), H1171 [21JA]

——— prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances (see H.R. 8005), H2620 [19MR]

——— provide for death penalty for anyone who knowingly deals fentanyl to person who dies from use (see H.R. 8766), H3392 [12MY]

DEA: make permanent scheduling of benzimidazole-opioids known as nitazenes (see H.R. 7970), H2595 [18MR]

——— schedule MGM–15, MGM–16, synthetic 7-hydroxymitragynine, and mitragynine pseudoindoxyl as schedule I controlled substances, and expand enforcement against manufacturers and distributors of emerging synthetic opioids (see S. 5383), S4564 [7AU]

——— schedule synthetic 7-hydroxymitragynine as schedule I controlled substance (see H.R. 8000), H2620 [19MR]

Dept. of Agriculture: delay implementation of amendments to laws governing hemp production (see S. 3686), S257 [15JA] (see H.R. 7024), H717 [13JA]

——— maintain certain State and Tribal laws relating to hemp (see S. 4315), S1820 [16AP]

Dept. of Defense: improve access to certain medications under TRICARE program (see S. 4106), S1090 [17MR]

——— publish list of dietary supplement ingredients prohibited for use by members of Armed Forces (see S. 4626), S2443 [21MY] (see H.R. 8962), H3722 [21MY]

Dept. of Education: establish grant program to provide schools with opioid overdose reversal drugs and direct schools receiving Federal funds to report to certain Federal information systems any distribution of such drug (see H.R. 7994), H2620 [19MR]

——— prohibit award of Federal education funds to educational institutions and agencies that do not allow for religious exemptions to vaccination requirements (see S. 5128), S4266 [23JY]

——— provide grants for institutions of higher education to prevent alcohol and substance misuse (see H.R. 7019), H655 [12JA]

Dept. of HHS: adjust which engineered cyclic peptides are qualifying single source drugs relative to drug price negotiation program (see H.R. 8857), H3550 [15MY]

——— award grants to eligible entities to address maternal mental health conditions and substance use disorders relative to pregnant and postpartum individuals (see S. 4552), S2326 [18MY] (see H.R. 8811), H3529 [14MY]

——— carry out activities to eliminate hepatitis C virus in U.S. (see H.R. 9682), H4466 [14JY]

——— carry out national campaign to increase awareness of importance of maternal vaccinations for health of pregnant and postpartum individuals and their children (see S. 4132), S1205 [18MR] (see H.R. 8024), H2621 [19MR] (see H.R. 8153), H2790 [27MR]

——— collect data and report to Congress on cost to Medicaid program from hospital and emergency room visits related to marijuana use (see S. 4345), S1840 [20AP]

——— ensure that Federally-qualified health centers are not required to pay more than 340B ceiling price for covered outpatient drugs at time of purchase (see H.R. 7391), H2040 [5FE]

——— ensure that women seeking chemical abortion are made aware of risks involved (see H.R. 7237), H1912 [23JA]

——— establish demonstration program to award grants to States to improve provision of recommended immunizations for children, adolescents, and adults through use of mobile vaccination units (see H.R. 7465), H2118 [10FE]

——— establish fair prices for prescription drugs (see H.R. 9040), H3735 [26MY]

——— establish interagency working group on peer-to-peer behavioral health programs for law enforcement officers and first responders (see H.R. 8493), H3091 [23AP]

——— establish pilot program to award grants to eligible entities to expand forensic assertive community treatment team programs (see H.R. 9669), H4466 [14JY]

——— establish program to develop antimicrobial innovations targeting most challenging pathogens and most threatening infections (see S. 4875), S3058 [23JN]

——— establish program to develop innovative antimicrobial drugs targeting most challenging pathogens and most threatening infections (see H.R. 7352), H2029 [4FE]

——— establish program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals (see S. 4512), S2278 [13MY]

——— improve access to pre-exposure prophylaxis (PrEP) to reduce transmission of HIV (see S. 3990), S802 [4MR] (see H.R. 7853), H2471 [5MR]

——— issue guidance on strategies under Medicaid and Children’s Health Insurance Program to increase mental health and substance use disorder care provider education, training, recruitment, and retention (see H.R. 9867), H5175 [22JY]

——— issue guidelines for addressing nitazene overdoses (see H.R. 8192), H2821 [2AP]

——— make determinations of exclusivity periods for which licensed biological products are eligible (see S. 4332), S1821 [16AP]

——— make updates to National Vaccine Injury Compensation Program (see H.R. 9672), H4466 [14JY]

——— modernize clinical trials and remove barriers for participation in clinical trials (see S. 4440), S2128 [29AP]

——— promote price transparency in health care sector (see H.R. 9393), H4205 [23JN]

——— provide better protections and support for children raised by grandparents or other kinship families outside foster care system due to parental drug or alcohol abuse (see S. 5065), S4230 [22JY] (see H.R. 9878), H5176 [22JY]

——— provide for appropriate cost-sharing for insulin products covered under private health plans (see S. 4512), S2278 [13MY]

——— provide funding for trained school personnel to administer drugs and devices for emergency treatment of known or suspected opioid overdose (see S. 3588), S89 [7JA] (see H.R. 9251), H4085 [10JN]

——— release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers (see H.R. 9699), H4543 [15JY]

——— release of documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers (see S. 4355), S1857 [21AP]

——— require community health centers to provide behavioral and mental health and substance use disorder services (see H.R. 8201), H2824 [6AP]

Dept. of Homeland Security: develop performance metrics relating to detection, deterrence, and seizure of fentanyl (see H.R. 8535), H3123 [27AP]

——— making continuing appropriations for certain employees and contractors of U.S. Customs and Border Protection and U.S. Immigration and Customs Enforcement in event of Government shutdown (see S. 3681), S257 [15JA]

——— require Science and Technology Directorate to work with DEA to develop greater capacity to detect, identify, and disrupt illicit substances, such as nitazenes, in very low concentrations (see H.R. 8022), H2621 [19MR]

Dept. of HUD: repeal Fair Housing Act provisions that allow landlords to deny housing to individuals with prior drug distribution convictions (see H.R. 7765), H2368 [3MR]

Dept. of Justice: establish grants to combat opioid trafficking (see H.R. 8818), H3530 [14MY]

——— provide direct hire authority to appoint qualified candidates to DEA positions in locations deemed necessary to support DEA mission (see H.R. 7413), H2094 [9FE]

Dept. of Labor: impose penalties on third party administrators who withhold certain data from health plan fiduciaries and ensure that data is subject to existing privacy and antidiscrimination laws (see H.R. 9486), H4262 [25JN]

——— issue guidance and regulations regarding opioid overdose reversal medication and employee training (see S. 3812), S552 [10FE] (see H.R. 7479), H2118 [10FE]

——— provide States and local areas information on best practices to address effects of substance use disorder on workforce and provide grants for training related to treatment and prevention (see S. 5263), S4475 [5AU] (see H.R. 8203), H2824 [6AP]

Dept. of Veterans Affairs: carry out pilot program to expand access to virtual-based opioid treatment for covered veterans (see H.R. 10037), H5213 [3AU]

——— eliminate copayments for medicines relative to preventive health services (see S. 4217), S1668 [26MR]

——— establish Office of Novel Therapeutics within Veterans Health Administration (see S. 4220), S1668 [26MR]

——— expand access to Veterans Community Care Program to include certain veterans seeking mental health or substance-use services (see H.R. 8737), H3391 [12MY]

——— furnish stellate ganglion block to veterans with post-traumatic stress disorder (see H.R. 8763), H3392 [12MY]

——— improve schedule for rating disabilities (see H.R. 8066), H2675 [24MR]

——— make opioid overdose rescue medications available to veterans and their caregivers (see S. 3758), S442 [2FE]

——— modify Precision Medicine for Veterans Initiative (see H.R. 8115), H2776 [26MR]

——— transmit veteran’s history of opioid prescriptions to Community Care health care provider (see H.R. 8679), H3340 [7MY]

Dept of HHS: modify mental health and substance use disorder services grants for students in higher education and National Suicide Prevention Lifeline program to address youth suicide prevention and intervention (see S. 5305), S4514 [6AU]

Depts. of Defense and Veterans Affairs: set maximum cost-sharing amount for prescription drugs for Armed Forces members and veterans and set maximum price for prescription drugs procured by Federal agencies (see H.R. 8667), H3340 [7MY]

Depts. of HHS and HUD: award grants to improve access to, develop, or expand, services that provide individuals with transportation to or from substance use disorder treatment or supportive services (see H.R. 8916), H3668 [20MY]

Depts. of HHS and State: formulate strategy to secure support from foreign countries, multilateral organizations, and others to facilitate development and commercialization of qualified pandemic or epidemic products (see H.R. 7879), H2476 [9MR]

Diseases and disorders: mitigate effects of coronavirus pandemic on incentives for development of orphan drugs (see H.R. 7693), H2327 [25FE]

——— protect against seasonal and pandemic influenza (see H.R. 8447), H3067 [22AP]

FDA: accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing reciprocal approval mechanism with trusted international regulatory authorities (see H.R. 7953), H2550 [17MR]

——— allow digital communication of prescribing information for drugs, including biological products (see S. 5242), S4432 [4AU]

——— amend treatment of homeopathic drug products (see S. 4692), S2576 [4JN] (see H.R. 7050), H892 [14JA]

——— authorize use of investigational individualized medical treatments by patients diagnosed with life-threatening disease or condition or severely debilitating illness (see S. 4698), S2664 [8JN] (see H.R. 9190), H3990 [8JN]

——— clarify and affirm preemptive authority over dietary supplement regulation (see H.R. 7366), H2030 [4FE]

——— clarify process for denying certain petitions whose primary purpose is to delay approval of application submitted relative to certain drugs (see H.R. 8908), H3627 [19MY]

——— codify that default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy (see H.R. 9661), H4466 [14JY]

——— enhance ability of outsourcing facilities to mitigate drug shortages by allowing short-term period to continue supplying market after drug is in shortage (see H.R. 7528), H2217 [12FE]

——— enhance drug manufacturing amount information reporting (see H.R. 8339), H2959 [16AP]

——— establish new prohibited acts relative to dietary supplements (see S. 3797), S509 [5FE] (see H.R. 7407), H2041 [5FE]

——— expand certain authorities relative to recall of controlled substances to apply to all drugs (see H.R. 7980), H2596 [18MR]

——— improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (see S. 3697), S290 [27JA]

——— prevent importation of counterfeit, unapproved, misbranded, or adulterated drugs from China or other foreign countries and establish enhanced safeguards for imported drug products (see S. 5043), S4187 [21JY]

——— prohibit Risk Evaluation and Mitigation Strategy (REMS)-certified provider from prescribing mifepristone without in-person visit and medical license in State in which patient resides (see H.R. 9421), H4244 [24JN]

——— provide for expedited approval of priority nonprescription drugs (see H.R. 9774), H4680 [20JY]

——— provide for regulation of cannabinoid hemp products (see H.R. 7212), H1349 [22JA]

——— require drug labeling to include original manufacturer and supply chain information (see S. 3788), S509 [5FE] (see H.R. 8269), H2885 [14AP]

——— require manufacturers of dietary supplements to list dietary supplements (see S. 3677), S257 [15JA] (see H.R. 8370), H2994 [20AP]

——— require regulatory review of pharmaceutical products from Chinese entities (see S. 4327), S1821 [16AP]

——— respect scientific judgment that mifepristone is safe and effective and ensure access to lifesaving, time-sensitive medication abortion care in U.S. is equitable and based on science (see S. Res. 732), S2305 [14MY] (see H. Res. 1285), H3531 [14MY]

——— set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions (see S. 3716), S344 [28JA]

——— set forth requirements for regulation of nitrous oxide products (see S. 4997), S4107 [15JY]

——— streamline review of biosimilar biological products (see S. 5059), S4188 [21JY]

——— strengthen regulation of compounding pharmacies and outsourcing facilities (see S. 3794), S509 [5FE]

——— waive manufacturer payment of user fees during Federal shutdown to provide for continued review of human drug and device submissions during appropriations lapse (see H.R. 9635), H4379 [9JY]

——— withdraw approval of mifepristone for termination of intrauterine pregnancy (see S. 4066), S1009 [11MR] (see H.R. 7902), H2481 [12MR]

Federal Railroad Administration: allow only U.S. citizens and permanent residents with reporting location in U.S. to operate trains crossing U.S. southern border and ensure that inspections are not unnecessarily delayed (see H.R. 8468), H3090 [23AP]

Fentanyl Prevention and Awareness Day: designate (see S. Res. 846), S4564 [7AU]

Financial institutions: create protections for financial institutions that provide financial services to State-sanctioned marijuana businesses and service providers for such businesses (see S. 4942), S3202 [24JN] (see H.R. 9471), H4262 [25JN]

Food industry: provide for regulation of hemp-derived beverages (see H.R. 10079), H5229 [10AU]

FTC: report to Congress on ability of minors to access fentanyl through social media platforms (see S. 3618), S161 [13JA]

GAO: conduct study and submit report on price-related compensation and payment structures in prescription drug supply chain (see S. 3751), S377 [29JA]

——— evaluate and report on in-patient and outpatient drug treatment capacity, availability, and needs of U.S. relative to opioid-use disorders (see H.R. 9676), H4466 [14JY]

Government: prohibit Federal agencies from taking adverse action due to provision of business assistance to cannabis-related legitimate businesses (see H.R. 7987), H2596 [18MR]

——— prohibit monitoring and regulation of water systems for purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care (see H. Res. 1389), H4246 [24JN]

Health: address high costs of health care services, prescription drugs, and health insurance coverage in U.S. (see H.R. 8840), H3531 [14MY]

——— end liability shield for vaccine manufacturers (see S. 3853), S578 [11FE]

——— provide private right of action for children and parents of children whose healthy body parts have been damaged by medical professionals practicing or participating in certain interventions (see H.R. 7651), H2258 [23FE]

Health care facilities: expand access to methadone through alternative care models using pharmacies (see S. 4941), S3202 [24JN] (see H.R. 9790), H4681 [20JY]

Health care professionals: protect religious freedom of pharmacists choosing not to dispense or sell abortion-inducing drugs (see H.R. 8366), H2994 [20AP]

Health Resources and Services Administration: maintain Rural Communities Opioid Response Program (see S. 5207), S4407 [3AU]

——— provide greater stability, clarity, and transparency in 340B drug discount program (see S. 5244), S4474 [5AU]

——— strengthen 340B drug discount program (see H.R. 9599), H4374 [6JY]

Immigration: secure U.S. borders and reform immigration policies (see H.R. 9199, 9200), H3991 [8JN] (see H.R. 9773), H4680 [20JY]

Immigration and Nationality Act: amend definition of aggravated felony to include certain serious drunk driving offenses (see S. 3584), S89 [7JA] (see H.R. 8302), H2924 [15AP]

Income: prohibit kickbacks to pharmacy benefit managers (see H.R. 7895), H2481 [12MR]

Information technology: modify requirements relating to prescription of controlled substances via Internet (see H.R. 6994), H615 [9JA]

Insulin: reduce price of insulin, require pharmacy benefit managers to pass-through manufacturer rebates for insulin products, and promote generic and biosimilar competition (see S. 4189), S1614 [25MR]

Insurance: ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care (see S. 4027), S915 [9MR]

——— establish public health plan (see H.R. 9702), H4544 [15JY]

——— preserve patient access to health care providers and prescription drug coverage under Medicare and individual market plans (see S. 4924), S3201 [24JN]

——— require group health plans and group and individual health insurance provide benefits for items and services to address harms caused by sex-rejecting procedures and restore healthy human form and functioning (see S. 5030), S4138 [16JY] (see H.R. 9743), H4622 [16JY]

——— require group health plans and health insurance issuers providing coverage for mental health and substance use disorder services to eliminate cost-sharing from pregnancy diagnosis to 1-year postpartum (see S. 3698), S290 [27JA] (see H.R. 7227), H1350 [22JA]

——— require health insurance coverage of drugs indicated for treatment of autoimmune diseases and certain blood disorders (see H.R. 9192), H3990 [8JN]

——— require health insurance providers to cover oral cancer drugs on terms no less favorable than for cancer medications administered by health care provider (see S. 5004), S4107 [15JY]

——— require out-of-pocket expenditures for drugs to count towards individual’s deductible and out-of-pocket maximum (see H.R. 8270), H2885 [14AP]

Law enforcement: focus limited Federal resources on most serious offenders by modifying sentencing guidelines for certain drug offenses (see S. 3959), S731 [2MR]

Marijuana: create safe harbor for insurers engaging in business of insurance in connection with cannabis-related business (see S. 5049), S4188 [21JY]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses (see S. 5022), S4137 [16JY]

Medicaid: codify value-based purchasing arrangements and reforms relative to price reporting under such arrangements (see H.R. 7871), H2476 [9MR]

——— ensure adequate access to vaccines under Vaccines for Children program (see H.R. 8425), H3045 [21AP]

——— ensure coverage of mental health or substance use disorder services and primary care services furnished on same day (see S. 5236), S4432 [4AU] (see H.R. 9847), H5174 [22JY]

——— repeal budget neutrality requirement for certain demonstration projects (see H.R. 8234), H2830 [9AP]

Medicare: establish coverage for certain residential substance use disorder services (see H.R. 9538), H4363 [30JN]

——— expand eligibility for incentives under health professional shortage area bonus program to practitioners furnishing mental health and substance use disorder services (see H.R. 7324), H1975 [3FE]

——— provide coverage for pre-exposure prophylaxis (PrEP) furnished by pharmacists (see H.R. 7189), H1171 [21JA]

——— provide review process for adverse national coverage determinations relative to drug coverage of certain new, innovative treatments (see H.R. 9418), H4244 [24JN]

——— require Medicare Payment Advisory Commission reports to Congress on arrangements with pharmacy benefit managers relative to prescription drug plans and Medicare Advantage prescription drug plans (see S. 3729), S377 [29JA]

——— require prescription drug plan sponsors of part D prescription drug plan that use formulary to include certain generic drugs and biosimilar biological products on such formulary (see H.R. 8143), H2789 [27MR]

——— require sponsors of prescription drug plans and Medicare Advantage organizations offering such plans under part D to include certain drugs and biosimilar biological products on formulary (see S. 4323), S1820 [16AP]

Mental health: accelerate development of, and access to, psychedelic drugs that could save lives and reverse crisis of serious mental illness in U.S. (see H.R. 9559), H4364 [30JN]

Methadone: revise Dept. of HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and require Dept. of Transportation to include testing for methadone use in drug tests (see H.R. 7967), H2550 [17MR]

Middle East: modify interagency strategy to disrupt and dismantle narcotics production and trafficking and affiliated networks in Middle East (see H.R. 7180), H1171 [21JA]

National Fentanyl Awareness Day: designate (see S. Res. 704), S2129 [29AP] (see H. Res. 1234), H3295 [29AP]

National Naloxone Awareness Day: designate (see S. Res. 770), S2784 [15JN]

National security: alter definitions of ‘‘prohibited technology’’ and ‘‘notifiable technology’’ to include biotechnology (see S. 5316), S4515 [6AU]

NIH: establish National Institute for Biomedical Research and Development (see H.R. 7854), H2471 [5MR]

——— require National Institute of Allergy and Infectious Diseases to award competitive grant for Antibiotic Resistance Leadership Group to facilitate clinical research network on antibiotic resistance (see S. 5237), S4432 [4AU]

Organized Crime Drug Enforcement Task Forces: combat transnational organized crime and reduce availability of illicit narcotics in U.S. by using prosecutor-led, multi-agency approach to enforcement (see S. 4004), S881 [5MR]

Patient Protection and Affordable Care Act: ensure taxpayer funds for health insurance coverage are available only to U.S. citizens, nationals, or aliens lawfully present (see H.R. 7817), H2470 [5MR]

Pharmaceuticals: prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers (see S. 3822), S552 [10FE]

——— prohibit pharmacy benefit managers and pharmacies from being under common ownership (see S. 4509), S2277 [13MY] (see H.R. 8779), H3452 [13MY]

Public Health Service Act: prohibit treatment of biologic as biological product based solely on presence of protein that is clinically inactive component in such biologic (see H.R. 8630), H3330 [30AP]

Social Media Harms Victim Remembrance Day: designate (see S. Res. 761), S2698 [9JN]

Social Security: affirm importance to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations (see S. Res. 579), S115 [8JA]

States: increase compliance with Prescription Drug Monitoring Program (PDMP) requirements by veterinarians (see H.R. 8983), H3723 [21MY]

Substance Abuse and Mental Health Services Administration: award grants to States to expand access to clinically appropriate services for opioid abuse, dependence, or addiction (see H.R. 9675), H4466 [14JY]

Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act: provide funding for programs and activities (see S. 4895), S3200 [24JN] (see H.R. 9759), H4623 [16JY]

Tardive Dyskinesia Awareness Week: designate (see H. Res. 1265), H3342 [7MY]

Taxation: exclude from gross income certain compensation to clinical trial participants (see S. 5127), S4266 [23JY]

——— permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements (see S. 4587), S2415 [20MY] (see H.R. 8933), H3669 [20MY]

——— provide for credits against tax for domestic manufacturing of critical medical supplies and drugs (see S. 4994), S4107 [15JY]

Trump, President: impeachment (see H. Res. 1155), H2825 [6AP]

Venezuela: commend President Trump, Armed Forces, intelligence community, and Dept. of Justice for success of ‘‘Operation Absolute Resolve’’ (see H. Res. 998), H893 [14JA]

——— support arrest of Nicolas Maduro under Operation Absolute Resolve and assist Venezuelan people in their fight for freedom (see S. Res. 582), S162 [13JA]

Women: allow greater access to safe and effective oral contraceptive drugs intended for routine use and direct GAO to conduct study on Federal funding of contraceptive methods (see H.R. 8083), H2710 [25MR]

World Hepatitis Day: observance (see H. Res. 1458), H5197 [23JY]

Messages

Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the U.S.: President Trump, S1838 [20AP], H2978 [20AP]

National Emergency Relative to U.S. Southern Border and Cartels and Other Transnational Organizations: President Trump, S159 [13JA], H691 [13JA]

Motions

Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S100 [8JA], S218 [14JA]

Remarks in House

Abortion: prohibit chemical abortions, H1342 [22JA], H4230 [24JN]

——— prohibit chemical abortions performed without presence of health care provider (H.R. 729), H4232 [24JN]

Accelerating Access to Critical Therapies for ALS Act: reauthorize (H.R. 8205), H4652–H4654 [20JY]

Armed Forces: remove from unauthorized hostilities against Venezuela (H. Con. Res. 68), H1317–H1325 [22JA]

——— remove from unauthorized hostilities against Venezuela (H. Con. Res. 68), unanimous-consent request, H1157 [21JA]

——— remove from unauthorized hostilities against Venezuela (S.J. Res. 90), H608 [9JA], H912 [15JA]

Black, Randy: Mothers for Awareness and Prevention of Drug Abuse (organization) Leadership Award recipient, E400 [30AP]

Brammer, Bob: Mothers for Awareness and Prevention of Drug Abuse (organization) Leadership Award recipient, E401 [30AP]

Chesterfield County, VA: anniversary of Helping Addicts Recover Progressively (HARP) Program, E143 [20FE]

Dept. of Agriculture: modify definition of hemp, H697 [13JA]

Dept. of Defense: prohibit TRICARE coverage of gender-related medical treatment, H5003–H5005 [21JY]

——— strike pilot program on modernization of drug testing using voice-based risk assessment technology to identify servicemembers for drug testing, H4970 [21JY]

Dept. of HHS: launch of White House Great American Recovery Initiative, H1984 [4FE]

Dept. of Homeland Security: develop performance metrics relating to detection, deterrence, and seizure of fentanyl (H.R. 8535), H4398 [13JY]

Dept. of Transportation: prohibit funding to implement advanced impaired driving technology motor vehicle safety standard, H1297, H1298 [22JA]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs, H3504 [14MY]

——— interim rule relative to determining disability benefit eligibility, H2238 [23FE]

——— reimburse State homes for cost of, or furnish to State homes, certain costly medications provided to veterans who receive nursing home care in such State homes (H.R. 1970), H3298 [30AP]

——— stellate ganglion block treatment for post-traumatic stress disorder funding, H3537, H3538 [15MY]

——— support research into psychedelic-assisted therapies to treat post-traumatic stress disorder and depression, H3503 [14MY]

Domestic policy: lower cost of consumer products and increase affordability, H2548 [17MR]

FDA: prohibit funding for Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, or Center for Devices and Radiological Health to issue or finalize guidance recommending or requiring testing in dogs, H3863 [4JN]

——— prohibit Risk Evaluation and Mitigation Strategy (REMS)-certified provider from prescribing mifepristone without in-person visit and medical license in State in which patient resides (H.R. 9421), H4232 [24JN]

——— publish final rule relative to nonclinical testing methods (H.R. 2821), H4639, H4640 [20JY]

——— publish final rule relative to nonclinical testing methods (S. 355), H941 [20JA]

Health: address high costs of health care services, prescription drugs, and health insurance coverage in U.S., H3554 [19MY]

Health care professionals: tribute to pharmacists, H1989 [4FE]

Immigration: secure U.S. borders and reform immigration policies, H709–H711, H713 [13JA]

Insurance: require group health plans and health insurance issuers providing coverage for mental health and substance use disorder services to eliminate cost-sharing from pregnancy diagnosis to 1-year postpartum (H.R. 7227), H2989 [20AP]

Medicare: assure pharmacy access and choice for beneficiaries (H.R. 4317), H928 [20JA]

——— establish improved Medicare for All national health insurance program (H.R. 3069), H111 [7JA]

Mental health: accelerate development of, and access to, psychedelic drugs that could save lives and reverse crisis of serious mental illness in U.S., H5055 [22JY]

Myers, Wayne: Pennsylvania Pharmacists Association Pharmacist of the Year award recipient, H2487 [16MR]

NIH: establish National Institute for Biomedical Research and Development (H.R. 7854), H2556 [18MR]

Pharmaceuticals: address overprescribing of antidepressants, H3719 [21MY]

——— improve services provided by pharmacy benefit managers, H2237 [23FE]

Tariff: terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada (H.J. Res. 72), H2154–H2161 [11FE]

——— terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada (H.J. Res. 72), unanimous-consent agreement, H2116 [10FE]

Taxation: strike provision of American Opportunity Tax Credit that denies credit to students with felony drug convictions, E334 [16AP]

Trump, President: condemn pardon of Juan O. Hernández, H3432, H3433 [13MY]

——— evaluation of administration, H1133 [21JA]

——— pardon of Juan O. Hernández, H2156 [11FE]

Venezuela: U.S. military and intelligence operation to capture Nicolas Maduro and his wife and extradite them to U.S. to face Federal drug, terrorism, and weapons charges, H137, H142, H148, H246 [8JA], H650–H654 [12JA]

Women: require warning label advising that effects of mifepristone can be counteracted and establish hotline to provide information to women seeking to counteract effects of mifepristone (H.R. 796), H4231 [24JN]

Remarks in Senate

Accelerating Access to Critical Therapies for ALS Act: reauthorize (S. 4472), S4425, S4426 [4AU], S4501 [6AU]

Agriculture: preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, S4469 [5AU]

Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 90), S56 [6JA]

——— remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S4 [5JA], S64, S69 [7JA], S96–S100 [8JA], S123 [12JA], S186, S212–S218 [14JA], S233 [15JA]

——— remove from unauthorized hostilities against Venezuela (S.J. Res. 98), motion to proceed, S218 [14JA]

——— remove from unauthorized hostilities against vessels operating in Caribbean Sea or Eastern Pacific Ocean (S.J. Res. 100), S56–S61 [6JA]

Bardstown, KY: tribute to Crume Drug Store, S4430 [4AU]

Budget: create point of order against reconciliation legislation that does not lower out-of-pocket health care costs, S1906 [22AP]

——— establish deficit-neutral reserve fund relative to reducing price of prescription drugs through adoption of Most Favored Nation drug pricing, S1915, S1916 [22AP]

——— establish deficit-neutral reserve fund to study economic impact of confidential drug pricing agreements between Federal agencies and pharmaceutical manufacturers, S1917 [22AP]

Children and youth: prohibit gender transition procedures on minors and impose civil penalties on persons who perform such procedures on minors (S. 4426), S2294 [14MY]

China: condemn Chinese President Xi Jinping for deceit, undermining prospects for peace and security, and orchestrating crimes against humanity (S. Res. 444), S2813 [16JN]

Dept. of Agriculture: delay implementation of amendments to laws governing hemp production, S4554 [7AU]

Dept. of Defense: investigate military operations targeting alleged drug traffickers in Ecuador, S1930 [22AP]

Dept. of HHS: issue guidance on whether hospital emergency departments should implement fentanyl testing as routine procedure for patients experiencing overdose (S. 921), S459 [3FE], S1559, S1560 [23MR]

Dept. of Homeland Security: require updates to northern border threat analysis and northern border strategy (S. 850), S4480, S4481 [5AU]

Dept. of Justice: establish task force to conduct investigations and make public findings and records relating to drug pricing agreements with pharmaceutical companies, S2562 [4JN]

FDA: improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (S. 3697), S292 [27JA], S3186 [24JN]

——— improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (S. 3697), unanimous-consent request, S3186 [24JN]

——— provide for regulation of cannabinoid hemp products, S4463 [5AU]

——— restore in-person dispensing requirements for chemical abortion drugs, S284 [27JA]

Fentanyl Prevention and Awareness Day: designate (S. Res. 846), S4553 [7AU]

Health: address health care affordability by establishing health savings accounts for out-of-pocket costs, increasing price transparency, and expanding access to safe and nutritious food, S1849 [21AP]

——— address high costs of health care services, prescription drugs, and health insurance coverage in U.S., S2679–S2681 [9JN]

——— support role of U.S. in helping save lives of children and protecting health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance (organization), S4208 [22JY]

Immigration and Nationality Act: amend definition of aggravated felony to include certain serious drunk driving offenses (S. 3584), S149 [13JA]

Insulin: reduce price of insulin, require pharmacy benefit managers to pass-through manufacturer rebates for insulin products, and promote generic and biosimilar competition (S. 4189), S2092 [29AP]

Insurance: require group health plans to provide exceptions process for any medication step therapy protocol (S. 2903), S2674 [9JN]

Kansas City, KS: tribute to Kansas City Police Dept., Narcotics Unit and Task Force officers, S88 [7JA]

Medicare: assure pharmacy access and choice for beneficiaries, S1701 [13AP]

——— assure pharmacy access and choice for beneficiaries (H.R. 4317), S3923 [14JY]

——— implementation of drug price negotiation program, S65 [7JA]

National Fentanyl Awareness Day: designate (S. Res. 704), S2089, S2109 [29AP]

National Naloxone Awareness Day: designate (S. Res. 770), S2792 [15JN]

Patents: address infringement of patents that claim biological products (S. 1041), S4198, S4199 [21JY]

Pharmaceuticals: improve services provided by pharmacy benefit managers, S1701 [13AP]

——— lower prescription drug costs for consumers, S2868 [17JN]

Senate: legislative priorities, S560 [11FE]

Social Media Harms Victim Remembrance Day: designate (S. Res. 761), S3024 [22JN]

Social Security: affirm importance to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations (S. Res. 579), S119 [8JA]

Trump, President: condemn pardon of Juan O. Hernández, S2878, S2880 [17JN]

——— evaluation of administration relative to foreign policy, S4320–S4323 [29JY]

——— evaluation of administration relative to immigration, S2490 [2JN]

Venezuela: U.S. military and intelligence operation to capture Nicolas Maduro and his wife and extradite them to U.S. to face Federal drug, terrorism, and weapons charges, S4 [5JA], S20, S56–S61 [6JA], S64–S70, S72–S87 [7JA], S96–S100, S105, S108 [8JA], S233 [15JA]

Reports filed

Accelerating Access to Critical Therapies for ALS Act Reauthorization: Committee on Energy and Commerce (House) (H.R. 8205) (H. Rept. 119–733), H4378 [9JY]

——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 4472), S4137 [16JY]

Biosimilar Red Tape Elimination Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1954), S4282 [27JY]

Combating Illicit Xylazine Act: Committee on the Judiciary (Senate) (S. 545), S1820 [16AP]

Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 3788), S4283 [27JY]

Dept. of HHS Guidance on Whether Hospital Emergency Departments Should Implement Fentanyl Testing as Routine Procedure for Patients Experiencing Overdose: Committee on Health, Education, Labor, and Pensions (Senate) (S. 921), S343 [28JA]

Expedited Access to Biosimilars Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1414), S4282 [27JY]

FDA Modernization Act 3.0: Committee on Energy and Commerce (House) (H.R. 2821) (H. Rept. 119–706), H4124 [18JN]

Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 4189), S4563 [7AU]

Measuring Illicit Fentanyl Trafficking Act: Committee on Homeland Security (House) (H.R. 8535) (H. Rept. 119–742), H4407 [13JY]

Medication Affordability and Patent Integrity Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2658), S4297 [28JY]

PBM Kickback Prohibition Act: Committee on Education and Workforce (House) (H.R. 7895) (H. Rept. 119–729), H4368 [2JY]

Restoring Confidence in the World Anti-Doping Agency Act: Committee on Commerce, Science, and Transportation (Senate) (S. 233) (S. Rept. 119–111), S625 [23FE]

Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 3794), S4283 [27JY]

Texts of

H. Con. Res. 68, remove Armed Forces from unauthorized hostilities against Venezuela, H1317 [22JA]

H.J. Res. 72, terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada, H2154 [11FE]

H.R. 2821, FDA Modernization Act 3.0, H4639 [20JY]

H.R. 8205, Accelerating Access to Critical Therapies for ALS Act reauthorization, H4653 [20JY]

H.R. 8535, Measuring Illicit Fentanyl Trafficking Act, H4398 [13JY]

S. 850, Northern Border Security Enhancement and Review Act, S4481 [5AU]

S. 921, issue Dept. of HHS guidance on whether hospital emergency departments should implement fentanyl testing as routine procedure for patients experiencing overdose, S1559 [23MR]

S. 1041, Affordable Prescriptions for Patients Act, S4199 [21JY]

S. 3677, Dietary Supplement Listing Act, S259 [15JA]

S. 3797, Prohibiting Tianeptine and Other Dangerous Products Act, S512 [5FE]

S. 3959, Smarter Sentencing Act, S733 [2MR]

S. 3960, Smarter Pretrial Detention for Drug Charges Act, S735 [2MR]

S. 4472, Accelerating Access to Critical Therapies for ALS Act reauthorization, S4426 [4AU]

S. Res. 576, commend U.S. military action in Venezuela, S117 [8JA]

S. Res. 579, affirm importance of Social Security to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations, S118 [8JA]

S. Res. 582, support arrest of Nicolas Maduro of Venezuela under Operation Absolute Resolve and assist Venezuelan people in their fight for freedom, S163 [13JA]

S. Res. 704, National Fentanyl Awareness Day, S2135 [29AP]

S. Res. 732, respect FDA scientific judgment that mifepristone is safe and effective and ensure access to lifesaving, time-sensitive medication abortion care in U.S. is equitable and based on science, S2309 [14MY]

S. Res. 761, Social Media Harms Victim Remembrance Day, S2701 [9JN]

S. Res. 770, National Naloxone Awareness Day, S2791 [15JN]

S. Res. 846, Fentanyl Prevention and Awareness Day, S4569 [7AU]